eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2005
vol. 1
 
Share:
Share:
abstract:

ORIGINAL PAPER
Treatment of bifurcation lesions with a bifurcation-dedicated stent Multilink Frontier™. Long-term follow-up of 50 patients

Maciej Lesiak
,
Janusz Rzeźniczak
,
Jarosław Hiczkiewicz
,
Stefan Grajek
,
Małgorzata Pyda
,
Włodzimierz Skorupski
,
Przemysław Mitkowski
,
Marek Grygier
,
Marek Prech
,
Artur Baszko
,
Andrzej Cieśliński

Post Kardiol Int 2005; 1, 1: 35–43
Online publish date: 2005/09/19
View full text Get citation
 

Background:
Percutaneous interventions of coronary bifurcations have always been a difficult challenge, with a lower success and higher complication rate than most other lesion types.
Methods: Fifty patients with symptomatic stable or unstable angina and with bifurcation lesions were treated with Multilink Frontier™ bifurcation-dedicated stent. In-hospital, thirty-day and nine-month follow-up data were
obtained. Repeat coronary angiography was performed only in the case of recurrence of symptomatic ischaemia.
Results: The device was successfully implanted in 46 patients. During 30-day follow-up there were no cases of
death, stent thrombosis or Q-wave myocardial infarction (MI). In-hospital non-Q-wave MI was diagnosed in two patients. During long-term follow-up no patient died, there was one case of Q-wave MI, and five patients (10%) underwent repeat target-lesion revascularization because of restenosis.
Conclusions: Multilink FrontierTM, a stent specifically designed for treating bifurcation lesions can be used with a high procedural success rate, and a satisfactory clinical long-term outcome.
keywords:

coronary stenting, bifurcation lesion

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.